|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
RESEARCH ARTICLE |

1 Bone Diseases Group, Department of Biotechnology, Hoechst-Marion-Roussel, 111 route de Noisy, 93230 Romainville, France
2 Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
3 Departments of Cell Biology and Orthopaedics, Yale University School of Medicine, New Haven, CT 06510, USA
* Both authors equally contributed to this work
Author for correspondence (e-mail: sergio.romanroman{at}aventis.com)
Accepted March 7, 2001
The proteins of the hedgehog (Hh) family regulate various aspects of development. Recently, members of this family have been shown to regulate skeletal formation in vertebrates and to control both chondrocyte and osteoblast differentiation. In the present study, we analyzed the effect of Sonic hedgehog (Shh) on the osteoblastic and adipocytic commitment/differentiation. Recombinant N-terminal Shh (N-Shh) significantly increased the percentage of both the pluripotent mesenchymal cell lines C3H10T1/2 and ST2 and calvaria cells responding to bone morphogenetic protein 2 (BMP-2), in terms of osteoblast commitment as assessed by measuring alkaline phosphatase (ALP) activity. This synergistic effect was mediated, at least partly, through the positive modulation of the transcriptional output of BMPs via Smad signaling. Furthermore, N-Shh was found to abolish adipocytic differentiation of C3H10T1/2 cells both in the presence or absence of BMP-2. A short treatment with N-Shh was sufficient to dramatically reduce the levels of the adipocytic-related transcription factors C/EBP
and PPAR
in both C3H10T1/2 and calvaria cell cultures. Given the inverse relationship between marrow adipocytes and osteoblasts with aging, agonists of the Hh signaling pathway might constitute potential drugs for preventing and/or treating osteopenic disorders.
Key words: Sonic hedgehog, Bone morphogenetic protein 2, Osteoblast, Adipocyte, Differentiation
This article has been cited by other articles:
![]() |
P. J King, L. Guasti, and E. Laufer Hedgehog signalling in endocrine development and disease J. Endocrinol., September 1, 2008; 198(3): 439 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fontaine, W. Cousin, M. Plaisant, C. Dani, and P. Peraldi Hedgehog Signaling Alters Adipocyte Maturation of Human Mesenchymal Stem Cells Stem Cells, April 1, 2008; 26(4): 1037 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xu, S. Yu, C.-H. Hsu, J. Eguchi, and E. D. Rosen The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis PNAS, February 19, 2008; 105(7): 2421 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobune, J. Kato, Y. Kawano, K. Sasaki, H. Uchida, K. Takada, S. Takahashi, R. Takimoto, and Y. Niitsu Adenoviral Vector-Mediated Transfer of the Indian Hedgehog Gene Modulates Lymphomyelopoiesis In Vivo Stem Cells, February 1, 2008; 26(2): 534 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Caverzasio and D. Manen Essential Role of Wnt3a-Mediated Activation of Mitogen-Activated Protein Kinase p38 for the Stimulation of Alkaline Phosphatase Activity and Matrix Mineralization in C3H10T1/2 Mesenchymal Cells Endocrinology, November 1, 2007; 148(11): 5323 - 5330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Dwyer, N. Sever, M. Carlson, S. F. Nelson, P. A. Beachy, and F. Parhami Oxysterols Are Novel Activators of the Hedgehog Signaling Pathway in Pluripotent Mesenchymal Cells J. Biol. Chem., March 23, 2007; 282(12): 8959 - 8968. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lengner, M. Q. Hassan, R. W. Serra, C. Lepper, A. J. van Wijnen, J. L. Stein, J. B. Lian, and G. S. Stein Nkx3.2-mediated Repression of Runx2 Promotes Chondrogenic Differentiation J. Biol. Chem., April 22, 2005; 280(16): 15872 - 15879. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hata, R. Nishimura, M. Ueda, F. Ikeda, T. Matsubara, F. Ichida, K. Hisada, T. Nokubi, A. Yamaguchi, and T. Yoneda A CCAAT/Enhancer Binding Protein {beta} Isoform, Liver-Enriched Inhibitory Protein, Regulates Commitment of Osteoblasts and Adipocytes Mol. Cell. Biol., March 1, 2005; 25(5): 1971 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-j. Liu, E. Chang, J. Yu, C. S. Carlson, L. Prazak, X.-P. Yu, B. Ding, P. Lengyel, and P. E. D. Cesare The Interferon-inducible p204 Protein Acts as a Transcriptional Coactivator of Cbfa1 and Enhances Osteoblast Differentiation J. Biol. Chem., January 28, 2005; 280(4): 2788 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hu, M. J. Hilton, X. Tu, K. Yu, D. M. Ornitz, and F. Long Sequential roles of Hedgehog and Wnt signaling in osteoblast development Development, January 1, 2005; 132(1): 49 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roman-Roman, D.-L. Shi, V. Stiot, E. Hay, B. Vayssiere, T. Garcia, R. Baron, and G. Rawadi Murine Frizzled-1 Behaves as an Antagonist of the Canonical Wnt/{beta}-Catenin Signaling J. Biol. Chem., February 13, 2004; 279(7): 5725 - 5733. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Chan, D. Miao, R. Deckelbaum, I. Bolivar, A. Karaplis, and D. Goltzman Parathyroid Hormone-Related Peptide Interacts with Bone Morphogenetic Protein 2 to Increase Osteoblastogenesis and Decrease Adipogenesis in Pluripotent C3H10T1/2 Mesenchymal Cells Endocrinology, December 1, 2003; 144(12): 5511 - 5520. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Colnot, Z. Thompson, T. Miclau, Z. Werb, and J. A. Helms Altered fracture repair in the absence of MMP9 Development, September 1, 2003; 130(17): 4123 - 4133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Teh, S.-T. Wong, G. W. Neill, L. R. Ghali, M. P. Philpott, and A. G. Quinn FOXM1 Is a Downstream Target of Gli1 in Basal Cell Carcinomas Cancer Res., August 15, 2002; 62(16): 4773 - 4780. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Demer Adipose Rex: Fat and Fats That Rule Differentiation Circ. Res., February 22, 2002; 90(3): 241 - 243. [Full Text] [PDF] |
||||
![]() |
G. Rawadi, C. Ferrer, S. Spinella-Jaegle, S. Roman-Roman, Y. Bouali, and R. Baron 1-(5-Oxohexyl)-3,7-Dimethylxanthine, a Phosphodiesterase Inhibitor, Activates MAPK Cascades and Promotes Osteoblast Differentiation by a Mechanism Independent of PKA Activation (Pentoxyfilline Promotes Osteoblast Differentiation) Endocrinology, November 1, 2001; 142(11): 4673 - 4682. [Abstract] [Full Text] [PDF] |
||||